Drug Pipeline

Briquilimab Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
6
Active Studies
1
Recruiting
4
Top Sponsors
Active Studies by Phase
Phase 2
2
Phase 1/2
4
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06736262 A Phase 2, Open-Label, Extension Study to Evaluate Long Term Safety and Clinical Activity… Urticaria Chronic Active, Not Recruiting
NCT05907746 Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in… GATA2 Active, Not Recruiting
Phase 1/2
NCT04784052 Depleted Donor Stem Cell Transplant in Children and Adults With Fanconi Anemia After… Fanconi Anemia Recruiting
NCT06162728 Dose Escalation Trial Of Safety, Pharmacokinetic/Pharmacodynamic And Preliminary Clinical… Chronic Spontaneous Urticaria Active, Not Recruiting
NCT05357482 Addition of JSP191 (C-kit Antibody) to Nonmyeloablative Hematopoietic Cell… Sickle Cell Anemia Active, Not Recruiting
NCT06145282 Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease… Sickle Cell Disease Active, Not Recruiting
Sponsors Running Briquilimab Trials
National Heart, Lung, and Blood Institute (NHLBI) (2) Jasper Therapeutics, Inc. (2) Porteus, Matthew, MD (1) National Institutes of Health Clinical Center (CC) (1)
Disease Areas
Sickle Cell Disease (2) Thalassemia (1)
Get alerts when Briquilimab trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free